Middle East And Africa Anthrax Treatment Market Size & Outlook, 2025-2033


Middle East And Africa Anthrax Treatment Market Insights

  • Based on Reed Intelligence findings, the Middle East And Africa Anthrax Treatment Market size reached USD 38.5 Million in 2024 and is expected to grow to USD 61.57 Million by 2033.
  • During 2026–2033, the market is forecasted to advance at a CAGR of 5.38%.
  • Cutaneous Anthrax represented the largest share of the By Disease Type market in terms of size in 2024.
  • Among the By Disease Type segments, Gastrointestinal Anthrax is forecasted to achieve the highest growth and remain the most lucrative through the forecast period.

Other Key Findings


  • Middle East And Africa held 9.11% share of the global Anthrax Treatment Market size in 2024.
  • United States is expected to remain the largest contributor to the global market size by 2033.
  • By 2033, United Arab Emirates is anticipated to record the highest growth in Middle East and Africa, with the market size expected to reach USD 34.26 Million.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 38.5 Million
Market Size In 2033 USD 61.57 Million
Largest segment Cutaneous Anthrax
Units Revenue in USD Million
CAGR 5.38% (2025-2033)
Segmnetation Covered
Middle East and Africa
  1. United Arab Emirates
  2. Saudi Arabia
  3. South Africa
  4. Egypt
  5. Nigeria
  6. Turkey
By Disease Type
  1. Cutaneous Anthrax
  2. Inhalation Anthrax
  3. Gastrointestinal Anthrax
  4. Injection Anthrax
By Treatment Type
  1. Antibiotics
  2. Immunoglobulins
  3. Others
By Route of Administration
  1. Parenteral
  2. Oral
By End-User
  1. Hospitals
  2. Clinics
  3. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports